A detailed history of Emerald Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Emerald Advisors, LLC holds 3,016 shares of JNJ stock, worth $468,988. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,016
Previous 3,027 0.36%
Holding current value
$468,988
Previous $442,000 10.41%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$145.48 - $167.38 $1,600 - $1,841
-11 Reduced 0.36%
3,016 $488,000
Q2 2024

Jul 15, 2024

SELL
$144.38 - $157.78 $16,459 - $17,986
-114 Reduced 3.63%
3,027 $442,000
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $21,730 - $22,783
-140 Reduced 4.27%
3,141 $496,000
Q4 2023

Jan 23, 2024

BUY
$145.6 - $158.88 $12,084 - $13,187
83 Added 2.6%
3,281 $514,000
Q3 2023

Oct 13, 2023

SELL
$155.75 - $174.48 $4,516 - $5,059
-29 Reduced 0.9%
3,198 $498,000
Q2 2023

Aug 02, 2023

BUY
$154.35 - $166.11 $17,132 - $18,438
111 Added 3.56%
3,227 $534,000
Q1 2023

Apr 07, 2023

BUY
$151.05 - $180.26 $1,812 - $2,163
12 Added 0.39%
3,116 $482,000
Q4 2022

Jan 20, 2023

BUY
$160.2 - $179.79 $14,097 - $15,821
88 Added 2.92%
3,104 $0
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $9,195 - $10,232
57 Added 1.93%
3,016 $493,000
Q2 2022

Aug 01, 2022

BUY
$168.19 - $186.01 $7,736 - $8,556
46 Added 1.58%
2,959 $525,000
Q1 2022

Apr 26, 2022

BUY
$158.14 - $179.59 $14,548 - $16,522
92 Added 3.26%
2,913 $516,000
Q4 2021

Jan 19, 2022

BUY
$155.93 - $173.01 $439,878 - $488,061
2,821 New
2,821 $483,000
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $388,767 - $538,657
-3,498 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $445,995 - $512,247
3,498 New
3,498 $520,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $407B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Emerald Advisors, LLC Portfolio

Follow Emerald Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.